RPTECH

Wait 5 sec.

RPTECHRashi Peripherals LimitedNSE:RPTECHlokeshpariharRashi Peripherals Limited (RPTECH), one of India’s top IT product distributors, has been experiencing a strong chart trajectory—recently hitting an all-time 52-week high of ₹812.85 before stabilizing around ₹783. This upward momentum is driven by several fundamental, structural corporate catalysts: 💥 The AI PC "Super Cycle" & Tech Inflection: Management has flagged the entry into a technology "super cycle," driven by a massive surge in AI-enabled notebook demand (which jumped 129% YoY in India) and firm component pricing (DRAM, NAND, GPUs). Furthermore, the company is chasing a massive ₹20,000–₹25,000 crore national AI data center project pipeline, building on its execution of India's largest AI data center project (the ₹2,000 crore Yotta project utilizing 4,000 GPUs). 📈 Blockbuster Q4 Earnings & Absolute Profit Re-rating: In its full-year disclosures, RPTECH reported explosive numbers that caught institutional attention. Q4 revenue grew 51% YoY to ₹4,489 crore, while Q4 Profit After Tax (PAT) skyrocketed 65% to ₹86.8 crore. For the full fiscal year, the company clocked a record ₹15,827 crore in revenue, proving that operating leverage is expanding its absolute bottom line despite inherently thin distribution margins. 🚀 The Semiconductor Surge & Dell Expansion: The company's high-margin, high-ROCE semiconductor business registered an incredible 131% YoY growth, prompting the creation of a dedicated subsidiary to aggressively scale this segment. Concurrently, RPTECH is rapidly ramping up its strategic partnership with Dell (covering PCs, servers, and enterprise storage), tracking to move Dell from a low single-digit percentage of revenue into a double-digit contributor. 🛡️ Favorable Regulatory & Credit Re-affirmations: Operationally, the company cleared near-term regulatory hurdles with favorable customs department rulings passed in May 2026. Additionally, CRISIL re-affirmed its robust credit ratings (Long Term: CRISIL AA- / Stable; Short Term: CRISIL A1+), allowing the company to sustain a lower cost of capital as it expands its working capital cycle to support its 20% forward CAGR growth guidance.